Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Feb, 9 2026
Jan, 5 2025
Jul, 22 2026
Jul, 8 2026
Oct, 18 2024